Shay Capital LLC Roivant Sciences Ltd. Transaction History
Shay Capital LLC
- $608 Million
- Q4 2024
A detailed history of Shay Capital LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Shay Capital LLC holds 15,478 shares of ROIV stock, worth $169,793. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,478
Previous 16,228
4.62%
Holding current value
$169,793
Previous $187,000
2.14%
% of portfolio
0.03%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$722 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$681 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$524 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$484 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$388 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.73B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...